plutonium....@gmail.com
unread,Aug 22, 2022, 3:48:50 PM8/22/22You do not have permission to delete messages in this group
Sign in to report message
Either email addresses are anonymous for this group or you need the view member email addresses permission to view the original message
to
Moron CEO Emma Walmsley of GSK, 22Aug2022, vacate GSK,HLN #711 Optimal Strategy of Playing the StockMarket via VonNeumann Game Theory.
I have seen some stupid CEO's in my lifetime of stock market investing, and Moron Emma Walmsley with her 5 for 4 reverse stock split, stealing 140 shares of 700 GSK from AP is a example of a moron CEO.
Where did my 140 shares disappear? Did it go to pay for brokers fee for her stupid spin off of Haleon HLN? Or did it go to enrich the coffers of GSK to use to buy other companies?
The only time you do reverse stock splits is when the company is in trouble, or, you want to screw the shareholders.
And then, just a few weeks after the reverse stock split is this news of a mountain avalanche of lawsuits on Zantac.
No, AP is not going to wade through years of court battles on Zantac, no, I sell all GSK and HLN today, and with the proceeds I buy a safe company, Verizon and AT&T.
Sold 700 Haleon, HLN at 6.15 per share.
Sold 560 GSK, at 34.04 per share.
Bought 500 VZ at 44.14 per share.
Bought 70 AT&T at 18.11 per share.
I suspect what happened at GSK, was the previous CEO was not well liked, and as the Roman emperors taught us in history lessons, that a ruler who wants to look good in the future history-- finds the most incapable moron to fill his place. Then, after 10 years, he begins to look real good, compared to the morons thereafter. This is how Augustus Caesar wanted to go down in history-- the bright emperor because he made sure morons would follow him.
PORTFOLIO of PAF of 22Aug2022
T 35,770 AT&T
VZ 600
Discovery 8100
__________
44,470
And total share-wealth-units today is 44,470, and today is 2Aug2022.
I need to discuss in some length, the split personality of drug companies, they are one of the richest companies in the stock market. But they have a split personality-- for they are so easy to file lawsuits upon. It happened to Merck, to Johnson and Johnson, now to Glaxo.
They are rich because of their monopoly on drugs, yet in the same view, they are poor for they constantly face lawsuits. The alternative to pain and death is drugs. But in that dance of riches, is the dance of courtroom lawsuits. They survive the courtroom battles-- witness Merck, Johnson & Johnson, and I am sure Glaxo will come out of it.
But for a scientist who needs to focus his head and mind on science, I cannot afford a spare thought for -- How the hell is Glaxo today in court?
Before the 1990s, AP was almost all in drug companies. But then I learned this Achilles heel of drug companies-- rich one year-- poor the next.
You almost need entire Houses of Analysts covering just the lawsuits mounting up in each drug company.
AP, King of Science, especially physics-chemistry